Carbidopa
REF : C0460000
Descrição :Carbidopa European Pharmacopoeia (EP) Reference Standard
Clique para mais informações
Clique para mais informações
Categoria : Selected Certified Reference Materials
Descrição detalhada : Carbidopa is a dopaminergic drug, which is known to inhibit the conversion of dopa to dopamine. It is used in combination with levodopa for the effective treatment of restless legs syndrome and periodic leg movements in sleep., This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Sinónimos : (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate
Fórmula molecula r: C10H14N2O4 · H2O
Armazenamento : +2°C to +8°C
Embalagem : 1X1EA
Sinónimos : (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate
Fórmula molecula r: C10H14N2O4 · H2O
Armazenamento : +2°C to +8°C
Embalagem : 1X1EA
